A simple blood test may detect Crohn’s disease years before symptoms appear, according to a new study reported by SWNS. Canadian researchers say the discovery could enable earlier diagnosis and ...
John Ferguson does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...
A new test may get to the heart of your dementia risk several years before any symptoms emerge. Dementia, which affects over 6 million Americans, impacts memory, language and problem-solving skills.
A small study found that a blood test could identify whether someone had Chronic Fatigue Syndrome (CFS) with 92% accuracy. Because CFS and long COVID have some biological overlap, this research could ...
"No cancer signal detected." The blood test results popped up in my online health portal without much fanfare. A doctor would chat about them with me later, congratulating me on the "phew"-worthy ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. As part of its bid to transform the future of cancer screening and seize control of ...
FDA cleared the Elecsys pTau181 test as the first blood-based biomarker to aid in the initial assessment of Alzheimer's disease and other causes of cognitive decline that can be used in the primary ...
Share on Pinterest Scientists are getting closer to accurately and quickly diagnosing chronic fatigue syndrome. Santi Nuñez/Stocksy There is no single test to diagnose chronic fatigue syndrome (CFS), ...
Cancer screening is at a turning point. For decades, most tests focused on one form of the disease — like mammograms for breast cancer or colonoscopies for colorectal cancer — but new advances have ...
The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...
High nitrogen losses by ammonia volatilization are expected when urea is used as the source of N. The use of controlled-release urea and urease inhibitors are possible strategies to reduce such losses ...
The early signs of Alzheimer's disease—more frequent memory loss, increased confusion—can be difficult to detect, often delaying diagnosis. That could change with an inexpensive and noninvasive blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results